STRATA Skin Sciences, Inc. Stock Deutsche Boerse AG
Equities
E2O
US86272A3059
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.76 EUR | +24.50% |
|
-.--% | -22.95% |
May. 15 | STRATA Skin Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Transcript : STRATA Skin Sciences, Inc., Q1 2024 Earnings Call, May 15, 2024 |
Sales 2024 * | 31.16M 28.58M | Sales 2025 * | 33.82M 31.01M | Capitalization | 11.43M 10.48M |
---|---|---|---|---|---|
Net income 2024 * | -10M -9.17M | Net income 2025 * | -5M -4.59M | EV / Sales 2024 * | 0.37 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.34 x |
P/E ratio 2024 * |
-1.16
x | P/E ratio 2025 * |
-2.1
x | Employees | 99 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.41% |
Latest transcript on STRATA Skin Sciences, Inc.
1 day | +24.50% | ||
3 months | -3.09% | ||
6 months | -27.69% | ||
Current year | -22.95% |
![Extreme 2.76](/images/extremecours_fleche.png)
![Extreme 2.74](/images/extremecours_fleche.png)
![Extreme 2.74](/images/extremecours_fleche.png)
![Extreme 2.74](/images/extremecours_fleche.png)
![Extreme 2.74](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 18-04-09 |
Director of Finance/CFO | 42 | 21-07-05 | |
Shmuel Gov
COO | Chief Operating Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uri Geiger
CHM | Chairman | 56 | 18-05-28 |
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 18-04-09 |
Director/Board Member | 60 | 18-05-28 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.64% | 208B | |
+8.99% | 182B | |
+29.83% | 155B | |
+35.17% | 115B | |
+2.55% | 66.52B | |
+15.06% | 53.93B | |
-6.47% | 46.26B | |
-2.14% | 38.22B | |
+6.88% | 36.6B |
- Stock Market
- Equities
- SSKN Stock
- E2O Stock